Oral Paracetamol as Preemptive Analgesia for Labor Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is a double blinded randomized control trial assessing the use of Oral paracetamol in managing the intrapartum pain.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pre-emptive Paracetamol for Prevention of Intraoperative Shoulder Tip Pain

NCT04038307

Cesarean Section

UNKNOWN PHASE2/PHASE3

Efficacy of IV Acetaminophen for Pain Management

NCT02028715

Post-operative Pain

COMPLETED PHASE4

Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain

NCT03878082

Uterine Pain

COMPLETED NA

IV Acetaminophen for Acute Post Operative Pain in C-Section Patients

NCT02069184

Post-operative Pain

COMPLETED PHASE4

Preemptive Paracetamol for Postoperative Pain

NCT02425254

Pain Surgical Wound

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is a double blinded randomized control trial comparing the use of Oral paracetamol to placebo in managing the intrapartum pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Labor Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

paracetamol

paracetamol 2 tablets1000mg PO.

Group Type ACTIVE_COMPARATOR

paracetamol

Intervention Type DRUG

500 mg oral tablet

placebo

placebo 2 tablets containing Starch PO

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

paracetamol

500 mg oral tablet

Intervention Type DRUG

placebo

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* primigravida
* The gestational age between 37- 42 weeks
* Not seeking analgesia
* Singleton pregnancy
* vertex
* Spontaneous onset of labour
* 1st stage of labour (less than 5 cm)

Exclusion Criteria

* Extreme of age (below18-above 40)
* Multiparous
* Multiple gestation
* Malpresentation
* Congenital or acquired pelvic abnormalities(eg. Poliomyelitis)
* Any medical disorder with pregnancy
* Induction of labour
* Advanced 1st stage \> 5 cm
* Use of any other kind of analgesia before recruitment in the study
* Scared uterus
* Fetal distress

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No